Synopsis of recent research by authors named "Longkang Sang"
- Longkang Sang's research primarily focuses on the development of novel peptide-based therapeutic agents, particularly targeting cancer and dental diseases, utilizing their unique structural properties and mechanisms of action.
- In a 2024 study, Sang investigated the anti-cancer potential of Lycosin-I, a peptide from spider venom, which shows selective efficacy against leukemia through its multimodal mechanisms involving lipid binding and self-assembly into nanospheres.
- A 2022 study highlighted the creation of dual-sensitive antibacterial peptide nanoparticles designed to prevent dental caries by effectively targeting bacterial biofilms while minimizing adverse effects on normal oral microbiota.
